| Financial Year |
March 31 2023 |
| Monetary Funds |
803,124,284.24 |
| Held-for-trading Financial Assets |
53,054,411.71 |
| Notes Receivable |
2,619,975.55 |
| Accounts Receivable |
1,143,044,790.28 |
| Advances to Suppliers |
110,201,016.73 |
| Other Receivables |
194,389,033.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,149,620,845.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
192,200,995.23 |
| Total Current Assets |
5,242,323,251.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,833,589.88 |
| Long-term Equity Investment |
16,415,245.15 |
| Investment Properties |
12,021,220.16 |
| Fixed Assetes |
1,495,019,440.70 |
| Under-construction Projects |
308,743,020.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
664,013,084.75 |
| R&D expenses |
-- |
| Goodwill |
197,900,996.00 |
| Long-Term Deferred and Prepaid Expenses |
10,137,398.71 |
| Deferred Income Tax Assets |
142,421,266.42 |
| Other Non-Current Assets |
27,065,662.00 |
| Sub-Total of Non-Current Assets |
2,925,262,973.68 |
| Total Assets |
8,167,586,224.84 |
| Short-Term Loans |
152,545,710.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,412,250,058.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
87,139,771.35 |
| Taxes Payable |
62,641,449.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
366,698,404.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
396,883,421.53 |
| Other Current Liabilities |
672,351,686.23 |
| Sub-Total of Current Liabilities |
3,479,901,788.18 |
| Long-term Loans |
1,431,581,760.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
21,406,676.85 |
| Deferred Income Tax Liabilities |
4,928.15 |
| Other Non-Current Liabilities |
800,000,000.00 |
| Sub-Total of Non-Current Liabilities |
2,336,613,979.38 |
| Total Liabilities |
5,816,515,767.56 |
| Paid-In Capital(Or Share Stock) |
1,923,088,236.00 |
| Capital Surplus |
679,599,958.93 |
| Surplus Reserve |
250,456,638.37 |
| LESS:Treasury Stock |
52,020,804.45 |
| Undistributed Profits |
-636,316,628.18 |
| Minority Stockholder's Interest |
154,492,874.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,196,577,582.75 |
| Owner's Equity（Stockholder's Equity） |
2,351,070,457.28 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,167,586,224.84 |
